Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Johnstone

Showing results (161-170 of 352) with videos related to

Pageof 36
Sort By:
Nature Reviews. Cancer|October 22, 2021
Targeting transcription cycles in cancerStephin J Vervoort, Jennifer R Devlin, Nicholas Kwiatkowski, et al.
International Journal of Cancer|April 30, 2002
Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cellsAstrid A Ruefli, David Bernhard, Kellie M Tainton, et al.
Haematologica|December 30, 2020
Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myelomaMatteo Costacurta, Stephin J Vervoort, Simon J Hogg, et al.
Immunity|February 28, 2012
Constitutive type I interferon modulates homeostatic balance through tonic signalingDaniel J Gough, Nicole L Messina, Christopher J P Clarke, et al.
Clinical Epigenetics|November 19, 2020
Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemiaJessica M Salmon, Michael Bots, Eva Vidacs, et al.
Transplantation Proceedings|February 1, 1992
Molecular characterization of the polymorphic expression of CD46: a cell surface molecule protecting cells from complement attackS M Russell, R W Johnstone, A Wilton, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancerYuhchyau Chen, Kishan J Pandya, Richard Feins, et al.
Annals of Hematology|October 16, 2010
MLL-aberrant leukemia: complete cytogenetic remission following treatment with a histone deacetylase inhibitor (HDACi)Kate L Burbury, Mark J Bishton, Ricky W Johnstone, et al.
Molecular Cancer Therapeutics|May 17, 2008
Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsinAndrea Newbold, Ralph K Lindemann, Leonie A Cluse, et al.
Cornea|May 1, 1992
Cryopreservation of rabbit and cat corneas at -18 to -24 degrees CE W Johnstone, K A Williams, V A Lovric, et al.
Pageof 36

Showing results (161-170 of 352) with videos related to

Sort By:
Pageof 36
Nature Reviews. Cancer|October 22, 2021
Targeting transcription cycles in cancerStephin J Vervoort, Jennifer R Devlin, Nicholas Kwiatkowski, et al.
International Journal of Cancer|April 30, 2002
Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cellsAstrid A Ruefli, David Bernhard, Kellie M Tainton, et al.
Haematologica|December 30, 2020
Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myelomaMatteo Costacurta, Stephin J Vervoort, Simon J Hogg, et al.
Immunity|February 28, 2012
Constitutive type I interferon modulates homeostatic balance through tonic signalingDaniel J Gough, Nicole L Messina, Christopher J P Clarke, et al.
Clinical Epigenetics|November 19, 2020
Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemiaJessica M Salmon, Michael Bots, Eva Vidacs, et al.
Transplantation Proceedings|February 1, 1992
Molecular characterization of the polymorphic expression of CD46: a cell surface molecule protecting cells from complement attackS M Russell, R W Johnstone, A Wilton, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancerYuhchyau Chen, Kishan J Pandya, Richard Feins, et al.
Annals of Hematology|October 16, 2010
MLL-aberrant leukemia: complete cytogenetic remission following treatment with a histone deacetylase inhibitor (HDACi)Kate L Burbury, Mark J Bishton, Ricky W Johnstone, et al.
Molecular Cancer Therapeutics|May 17, 2008
Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsinAndrea Newbold, Ralph K Lindemann, Leonie A Cluse, et al.
Cornea|May 1, 1992
Cryopreservation of rabbit and cat corneas at -18 to -24 degrees CE W Johnstone, K A Williams, V A Lovric, et al.
Pageof 36